Stability of magistral phage preparations before therapeutic application in patients with chronic rhinosinusitis, sepsis, pulmonary, and musculoskeletal infections

Uyttebroek S, Bessems L, Metsemakers W-J, Debaveye Y, Van Gerven L, Dupont L, Depypere M, Wagemans J, Lavigne R, Merabishvili M, Pirnay J-P, Devolder D
,
et al
No abstract available
Keywords:

3107 Microbiology

,

31 Biological Sciences

,

Infectious Diseases

,

5.1 Pharmaceuticals

,

Infection

,

Humans

,

Bacteriophages

,

Rhinosinusitis

,

Phage Therapy

,

Sepsis

,

Bacterial Infections